Nuvaira Receives French Innovation Funding for AIRFLOW-3 Pivotal Trial

By In The News
May 2, 2019 in The Headlines

Recommended Posts

In The News

Posted May 2, 2019

- Share

Posted May 2, 2019

Novel program provides reimbursement for TLD therapy in France MINNEAPOLIS, May 2, 2019 /PRNewswire/ -- Nuvaira, developer of novel therapeutic strategies to treat obstructive lung diseases, has received acceptance from the Haute Autorité de Santé (HAS, the French health technology...

View the full article

Link to comment

Share on other sites

Archived

This topic is now archived and is closed to further replies.

Go to topic listing

Most Contributions
1. In The News
  222008
2. Jaydee
  17783
3. deicer
  13345
4. Kip Powick
  12311
5. dagger
  9614
Tell a friend
Love The Airline Website? Tell a friend!
- Email
- Share
Forum Statistics
- Total Topics
  
  272.4k
- Total Posts
  
  565k

Sign In

Nuvaira Receives French Innovation Funding for AIRFLOW-3 Pivotal Trial

Recommended Posts

In The News

Link to comment

Share on other sites

Archived

Most Contributions

Tell a friend

Forum Statistics

Browse

Activity

Support